MICHELLE GARBER: Open Payments
NPI 1235596669 · COSHOCTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,885 in 97 payments from 20 companies in 2025. Trend: 2023 $795 · 2024 $2,019 · 2025 $1,885
Food & beverage: $1,885
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $496 |
| ABBVIE INC. | 28 | $405 |
| Corcept Therapeutics | 11 | $223 |
| Novo Nordisk Inc | 14 | $157 |
| Edwards Lifesciences Corporation | 1 | $133 |
| Lilly USA, LLC | 4 | $62 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Alkermes, Inc. | 2 | $49 |
| Amgen Inc. | 3 | $46 |
| GlaxoSmithKline, LLC. | 2 | $40 |
Products named: Korlym, AIRSUPRA, FARXIGA, QULIPTA, BREZTRI, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), UBRELVY, Ozempic.
Industry payments across OH — which companies pay providers there.
